Sanjay Gajendra

Astera Labs President/COO Sanjay Gajendra sells 400,000 shares for $116.1M on scheduled 10b5-1 plan

Sanjay Gajendra executed 5 separate sales totaling 400,000 shares for $116,119,966.50 on 2026-05-21, reducing his holdings by 24.8% from 1,609,668 to 1,209,668 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-02, making it scheduled rather than discretionary. The stock trades at $318.72, up 49.8% over 30 days and 148.7% over 90 days, significantly outpacing the blended sale price of $290.30. His prior 5 trades at ALAB (all on 2026-05-07) showed 30-day and 90-day returns ranging from +19.0% to +26.6%, illustrating a pattern where post-sale price appreciation has exceeded the execution prices on this ticker.

Sanjay Gajendra (President, COO) executes scheduled 10b5-1 sale: 280,000 ALAB shares for $69,774,014.08

Sanjay Gajendra sold 280,000 shares (280.0K shares) across 6 separate transactions on 2026-05-19 for $69,774,014.08, reducing his holdings from 895,000 shares to 615,000 shares (-31.3%). This sale is part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-02, meaning the transactions were scheduled rather than discretionary. The stock currently trades at $297.84, 3.5% above its 52-week high of $287.70, and has gained 55.2% over 30 days and 129.7% over 90 days. At ALAB specifically, Gajendra's prior five sales on 2026-05-07 all showed positive subsequent returns (ranging from 19.0% to 26.6% over 30–90 days), though the current volatility context and scheduled nature of this transaction limit forward-looking inferences.

President/COO Gajendra Sanjay sells 95,444 shares (6.2% of holdings) for $21.5M at blended average $225.02 on 2026-05-18

Gajendra Sanjay, President and COO, executed 17 separate sales on 2026-05-18 totaling 95,444 shares for $21,476,948.62 at prices ranging from $216.46 to $235.41, with blended average price $225.02. The current price is $287.48, representing +9.4% above the 52-week high of $262.90, and the stock has advanced 63.5% over 30 days and 116.8% over 90 days. His prior sales at ALAB (5 trades on 2026-05-07) subsequently delivered positive 90-day returns ranging from 19.0% to 26.6%, meaning the stock rose after those sales—a pattern that did not align with downside prediction. Post-transaction holdings remain substantial at 1,435,857 shares (1.44M shares), representing a 6.2% reduction in position size.

ALAB President and COO Gajendra Sanjay sells ~49,400 shares in largest 23-trade disposition, marking 138th open-market sale in 36 months with uniformly poor prior timing.

Gajendra Sanjay, ALAB's President and COO, executed a large portfolio reduction by selling approximately 49,400 shares across 23 transactions on a single date, totaling roughly $9.8M in disposition value. The stock at the time was trading well below its 52-week high and has rebounded significantly over the prior three months, providing a backdrop where his sales occurred at elevated prices relative to recent weakness. However, Sanjay's insider trading record reveals a concerning pattern: every single one of his prior five sales at ALAB resulted in the stock rising afterward, meaning each sale was poorly timed from a hindsight perspective—he repeatedly exited before meaningful gains materialized. This is his 138th open-market sale across all holdings in the 36-month window, indicating a predominantly selling insider with no open-market purchases during this period. Notably, the company remains profitable with strong revenue growth, so the sales do not signal distress; rather, they reflect a consistent pattern of liquidation at a director-level executive who has never reversed course to buy back into this stock despite multiple poor-timing outcomes on prior exits.

Astera Labs President and COO Gajendra Sanjay sells $45.7M in shares, continuing a pattern of quarterly dispositions.

Gajendra Sanjay, President and COO of Astera Labs, executed a substantial sale of roughly 230,000 shares for nearly $46 million on a single trading day, marking his 115th open-market sale transaction over the past 36 months with zero open-market purchases in that window. The sale is noteworthy in scale and represents his continuing pattern of regular equity dispositions across quarterly windows. However, Sanjay's track record on timing has been consistently poor: all five of his prior same-ticker sales saw the stock rise in the following 30 and 90 days, indicating that he has repeatedly exited ahead of subsequent gains rather than ahead of declines. The company itself remains profitable with strong revenue growth, and the stock trades well below its 52-week high, having rallied significantly over the past month despite the pullback from earlier peaks. This sale occurs in a financially healthy company rather than one showing operational distress, which limits the signal that might otherwise come from such a large executive disposition.

Gajendra Sanjay (President/COO) sold 94,971 shares for $11,758,145.88 across 5 transactions on 2026-02-17

Gajendra Sanjay executed 5 separate sales totaling 94,971 shares for $11,758,145.88 on a single day, reducing his holdings by 5.8% from 1,626,272 shares to 1,531,301 shares. The blended average transaction price was $123.81, and the stock has since traded as high as $251.88 in the past 52 weeks but now sits at $132.62—already 47.4% below the yearly peak and down 27.8% over the past 30 days. Notably, this represents a continued pattern: Sanjay's prior 5 trades at Astera Labs, all executed on 2025-11-17, were each well-timed, with all five showing negative 90-day returns (ranging from -2.1% to -4.4%), indicating the stock declined after those sales. However, his broader cross-ticker track record shows a 90d well-timed rate of 35%, suggesting his timing acumen is not consistently exceptional. Against a backdrop of elevated volatility (down 6.5% over 90 days) and a stock trading well below its annual high, this large, multi-transaction sale by a President and COO merits attention as a potential signal of executive positioning during a period of sharp price decline.

ALAB COO Gajendra Sanjay sold 90,459 shares for $13,088,903.90 across 5 transactions on 2025-11-17; stock down -43.6% from 52-week high.

Gajendra Sanjay, President and COO of Astera Labs, executed 5 separate sales totaling 90,459 shares for $13,088,903.90 on 2025-11-17, with a blended average price of $144.69. His post-transaction holding of 1,599,750 shares represents a -5.4% reduction in stake. The timing coincides with significant recent downward momentum: the stock is -43.6% from its 52-week high of $251.88, -9.2% over the past 30 days, and -20.0% over the past 90 days. At the current price of $142.01, the transaction is now underwater relative to most execution prices. Notably, his cross-ticker track record shows a 90-day well-timed rate of 10.00%, while his same-ticker history at ALAB shows 2 of 5 prior sells were well-timed at the 90-day mark—modest indicators of historical sell timing—yet his immediate cross-ticker returns after prior sells averaged +52.9% at 90 days, suggesting those past sales typically preceded rallies rather than declines. The company remains fundamentally elevated, trading at a P/E of 120.35 on recent quarterly revenue of $230,575,000.00 and net income of $91,114,000.00, though it was unprofitable on a full-year basis.

President and COO Gajendra Sanjay sold 91,441 shares for $16,780,383.40 at blended average $183.51 on 2025-08-18

Gajendra Sanjay, President and COO, executed two separate sales totaling 91,441 shares for $16,780,383.40 at a blended average price of $183.51 on 2025-08-18. The sales reduced his holdings from 2,262,318 shares to 2,170,877 shares, a 4.0% reduction in his position. Notably, the transaction prices ($183.83 and $183.17) were executed near the company's 52-week high of $193.64; the stock is now at $172.45 (10.9% below the high), and has surged 41.5% over the trailing 30 days and 82.9% over 90 days. Sanjay had executed five additional sales at ALAB on 2025-08-07 with outcomes still not yet measurable, indicating consecutive days of disposition activity. With a P/E of 287.42 despite the company posting full-year negative net income (though the latest quarter shows $51.2M net income on $191.9M revenue), the valuation remains elevated even after the recent pullback.

Astera Labs President/COO Gajendra Sanjay sold 280,000 shares ($47.6M) in 10 transactions on 2025-08-07

Gajendra Sanjay, President and COO of Astera Labs, executed 10 separate open-market sales on 2025-08-07, liquidating 280,000 shares for $47,604,990.63 at prices ranging from $165.75 to $174.89, with a blended average of $170.02. His post-transaction holdings of 5,525,545 shares represent a 4.8% reduction from pre-transaction levels, yet he retains substantial ownership. The timing of this large, multi-tranche disposition occurs just four weeks after prior sales on 2025-07-09, during which his stock positions posted exceptional near-term returns (30-day gains of +80.7% to +82.6% on those recent trades). His cross-ticker trading history shows an average 90-day return of +142.8% following prior sells across all his holdings—a pattern suggesting poor sell timing overall (stocks typically rose after his exits). The current price of $179.28 now stands 5.4% above his blended transaction price of $170.02, and the stock has appreciated +79.5% over the past 30 days, indicating the market has continued its upward trajectory since his sales execution.

President/COO Gajendra Sanjay sells 165,000 ALAB shares for $16.3M on 2025-07-09; stock now -34.2% from 52-week high

Gajendra Sanjay, President and COO, executed 4 separate sales totaling 165,000 shares (165.0K shares) for $16,270,047.89 ($16.3M) at a blended average price of $98.61 on 2025-07-09. This represents a 19.2% reduction of his pre-transaction holdings from 860,000 shares to 695,000 shares (695.0K shares). The timing is notable: while shares traded at an average of $98.61 during the sale, the stock has since declined to $95.90 (current price) and sits 34.2% below its 52-week high of $145.81. His prior sales at ALAB show only one measurable outcome (the 2025-06-04 sale, which returned -7.4% over 30 days), providing limited same-ticker timing pattern data. The company's fundamentals present mixed signals: revenue growth of 242.2% year-over-year is robust, but the company remains unprofitable on a full-year basis despite recent quarterly profitability of $31.8M, and the P/E ratio of 383.60 reflects a stock trading at extreme valuation multiples. This sale by the company's operational leader occurs against a backdrop of valuation vulnerability and recent price momentum loss.